The Affordable Care Act has nearly died at least three times since the final bill took shape in 2010; with the re-election of Barack Obama, it is all systems go. But remember, the race to implement the program by 2014 is only the beginning, not the end, of health care reform.

A Federal Circuit panel again rules that Myriad Genetics’ patents covering BRCA genes isolated from the body are patent-eligible; the ACLU may request review by the full court or file a petition with the Supreme Court.

FDA and industry have reached agreement on four issues in the Prescription Drug User Fee Act reauthorization, including adjustments to risk-benefit policy and creation of a meta-analysis team.